Clinical Trial Update: Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient [Phase 2]

View source ↗

Summary

This update reports completion of a compassionate-use Phase 2 study of azimilide dihydrochloride at 125 mg daily in a single patient with congestive heart failu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Azimilide dihydrochloride (azimilide dihydrochloride)

Snippet

Sponsor: Forest Laboratories | Conditions: Congestive Heart Failure | Phase 2 | Status: COMPLETED